Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 7Unknown 3Withdrawn 1Terminated 1

Sponsor Class

OTHER 1NIH 1NETWORK 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Breast 3Other hematologic neoplasm 2Thoracic 1CNS 1

Conditions

Breast Neoplasms 2Carcinoma, Intraductal, Noninfiltrating 1Advanced Breast Cancer 1

Interventions

Cyclophosphamide 89Capecitabine 88Trastuzumab 81Docetaxel 81Paclitaxel 65Epirubicin 57pyrotinib 55Tamoxifen 54Letrozole 53Fulvestrant 49Vinorelbine 43Carboplatin 43Doxorubicin 41Radiotherapy 33Anastrozole 32exemestane 31Neoadjuvant Therapy 29palbociclib 27Drug Therapy 27Fluorouracil 24Bevacizumab 24pertuzumab 23Cisplatin 23eribulin 22Exercise 21130-nm albumin-bound paclitaxel 21Goserelin 20Gemcitabine 20Chemotherapy, Adjuvant 19Albumin-Bound Paclitaxel 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × In Situ Hybridization, Fluorescence × Breast × Clear all
NCT01424865 2015-05-08

Cancer Stem Cell Biomarkers as a Predictor of Response to Trastuzumab in Samples From Patients With Breast Cancer Previously Treated in the NSABP-B-31 Trial

NSABP Foundation Inc

Unknown
1,874 enrolled
Breast

Breast Neoplasms

NCT00671476 2014-01-10

Doxorubicin Hydrochloride Liposome in Treating Women With Ductal Carcinoma in Situ Undergoing Surgery

National Cancer Institute (NCI)

Phase NA Unknown
30 enrolled
Breast

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00874146 2010-09-02

Level of HER2-neu Gene Amplification an Response to Trastuzumab

Istituto Clinico Humanitas

Unknown
100 enrolled
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡